Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MLSS logo MLSS
Upturn stock ratingUpturn stock rating
MLSS logo

Milestone Scientific (MLSS)

Upturn stock ratingUpturn stock rating
$0.58
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: MLSS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $2.12

1 Year Target Price $2.12

Analysts Price Target For last 52 week
$2.12 Target price
52w Low $0.38
Current$0.58
52w High $1.39

Analysis of Past Performance

Type Stock
Historic Profit -48.8%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 51.01M USD
Price to earnings Ratio -
1Y Target Price 2.12
Price to earnings Ratio -
1Y Target Price 2.12
Volume (30-day avg) 2
Beta 0.8
52 Weeks Range 0.38 - 1.39
Updated Date 08/15/2025
52 Weeks Range 0.38 - 1.39
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.06

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-08-19
When -
Estimate -0.01
Actual -0.02

Profitability

Profit Margin -61.16%
Operating Margin (TTM) -89.49%

Management Effectiveness

Return on Assets (TTM) -44.58%
Return on Equity (TTM) -88.36%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 43526373
Price to Sales(TTM) 5.92
Enterprise Value 43526373
Price to Sales(TTM) 5.92
Enterprise Value to Revenue 5.05
Enterprise Value to EBITDA -6.86
Shares Outstanding 78477296
Shares Floating 62026904
Shares Outstanding 78477296
Shares Floating 62026904
Percent Insiders 21.45
Percent Institutions 5.95

ai summary icon Upturn AI SWOT

Milestone Scientific

stock logo

Company Overview

overview logo History and Background

Milestone Scientific Inc. was founded in 1989. It initially focused on computer-controlled drug delivery technology. It has evolved into a medical device company specializing in computerized anesthesia and drug delivery systems.

business area logo Core Business Areas

  • Dental: Focuses on the CompuDent system, a computer-controlled local anesthesia delivery system (CALADS) for dental applications, aiming to reduce patient anxiety and pain during injections.
  • Medical: Develops and markets the CompuFlo Epidural and intrathecal anesthesia delivery system, designed for precise drug delivery in pain management and other medical procedures.

leadership logo Leadership and Structure

Leonard Osser serves as the Chief Executive Officer. The company has a board of directors overseeing its strategic direction and operations. The structure includes sales, marketing, R&D, and manufacturing departments.

Top Products and Market Share

overview logo Key Offerings

  • CompuDent: A computer-controlled local anesthesia delivery system (CALADS) for dental use. Its market share is estimated to be less than 5% of the total local anesthesia delivery market, facing competition from traditional syringes and other CALADS systems. Competitors include Septodont, Dentsply Sirona, and other anesthesia delivery system manufacturers. Revenue information is not publicly disclosable.
  • CompuFlo Epidural: A system designed for precise drug delivery during epidural anesthesia procedures. Its market share in this segment is also relatively small, given the established techniques and competitors in the pain management device market. Competitors include Becton Dickinson, Smiths Medical, and other large medical device companies. Revenue information is not publicly disclosable.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is characterized by technological innovation, regulatory scrutiny, and competitive pressure. The market for anesthesia delivery systems is driven by the need for improved patient comfort and precise drug administration.

Positioning

Milestone Scientific is positioned as a provider of innovative computer-controlled drug delivery systems, focusing on improving precision and patient experience. It differentiates itself through its patented technology and targeted marketing towards specific applications like dental and epidural anesthesia.

Total Addressable Market (TAM)

The global market for anesthesia delivery systems is estimated to be in the billions of dollars. Milestone Scientific is positioned to capture a portion of this TAM by focusing on niche applications and technological advancements.

Upturn SWOT Analysis

Strengths

  • Patented technology for computer-controlled drug delivery
  • Focus on improving patient comfort and precision
  • Targeted marketing efforts
  • Specialized in dental and medical fields

Weaknesses

  • Limited market share compared to larger competitors
  • Reliance on specific product lines
  • Potential dependence on key personnel
  • Small market capitalization

Opportunities

  • Expansion into new applications and markets
  • Partnerships with dental and medical professionals
  • Increased adoption of CALADS technology
  • Acquisitions for scale

Threats

  • Competition from established medical device companies
  • Regulatory changes and approvals
  • Economic downturns affecting healthcare spending
  • Technological obsolescence

Competitors and Market Share

competitor logo Key Competitors

  • Dentsply Sirona (XRAY)
  • Becton Dickinson (BDX)
  • Septodont (Private)

Competitive Landscape

Milestone Scientific faces competition from larger, more established medical device companies. Its advantages include its patented technology and focus on niche applications. Disadvantages include its smaller size and limited resources.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been driven by product sales and market expansion efforts.

Future Projections: Future growth is projected to be driven by increased adoption of its products in dental and medical markets, as well as potential new product launches.

Recent Initiatives: Recent initiatives include expanding the sales team, marketing campaigns, and developing new product features.

Summary

Milestone Scientific is a small company in the medical device sector with innovative technology but limited market share. It faces competition from larger players but has growth potential through new applications and partnerships. Financial performance is key to monitor for long-term sustainability and expansion.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Milestone Scientific's investor relations website
  • SEC filings (e.g., 10-K reports)
  • Market research reports
  • Industry news articles

Disclaimers:

This analysis is based on publicly available information and estimates. It is not financial advice, and investors should conduct their own due diligence before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Milestone Scientific

Exchange NYSE MKT
Headquaters Roseland, NJ, United States
IPO Launch date 1995-11-03
CEO -
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 17
Full time employees 17

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.